In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Doximity Inc’s stock clocked out at $69.45, down -4.73% from its previous closing price of $72.90. In other words, the price has decreased by -$4.73 from its previous closing price. On the day, 1.97 million shares were traded.
Ratios:
To gain a deeper understanding of DOCS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 56.15. For the most recent quarter (mrq), Quick Ratio is recorded 8.67 and its Current Ratio is at 8.67. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on February 07, 2025, Upgraded its rating to Overweight and sets its target price to $78 from $31 previously.
On February 07, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $60 to $90.
On December 20, 2024, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $55.Stephens initiated its Equal-Weight rating on December 20, 2024, with a $55 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 12 ’25 when Yang Watkin Phoebe L. sold 2,889 shares for $75.19 per share. The transaction valued at 217,209 led to the insider holds 14,729 shares of the business.
Benjamin Regina M. sold 40,000 shares of DOCS for $3,045,883 on Feb 11 ’25. The Director now owns 16,618 shares after completing the transaction at $76.15 per share. On Feb 11 ’25, another insider, Wampler Kira Scherer, who serves as the Director of the company, sold 2,000 shares for $77.19 each. As a result, the insider received 154,385 and left with 16,618 shares of the company.
Valuation Measures:
As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 69.33, and their Forward P/E ratio for the next fiscal year is 48.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.59. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.69 while its Price-to-Book (P/B) ratio in mrq is 12.63.
Stock Price History:
Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $22.96. The 50-Day Moving Average of the stock is 13.80%, while the 200-Day Moving Average is calculated to be 61.60%.
Shares Statistics:
A total of 133.45M shares are outstanding, with a floating share count of 129.48M. Insiders hold about 31.00% of the company’s shares, while institutions hold 61.81% stake in the company.
